This infographic highlights the latest data and insights surrounding the 2023 preclinical ADC landscape, including:

  • A comprehensive overview of the drugs currently in development
  • Details on top targets and top moiety formats
  • Recent trends in the disease landscape
  • A breakdown of the 330 payloads being used in preclinical ADCs
  • Information on conjugation technologies

To learn more about this infographic, or how Beacon ADC can enhance your data needs and provide fast insights, please book a research session below or contact us directly on

Download our infographic for a thorough analysis of the ADC preclinical landscape in 2023


Find out more
All data in this infographic is available on Beacon ADC


 Discover Beacon ADC 

Speak with our team of experts

Our dedicated account and research teams are on hand to showcase how Beacon can help you find the answers to your ADC-related questions

Jia He Raj Kumar

Get Started

About Beacon

Beacon is the essential decision-support tool for developers of complex therapeutics. Our market-defining, proprietary ontologies, combined with the most accurate and comprehensive life sciences data, provide our customers with unparalleled visibility of the drug and trial landscape.

With Beacon, you can make drug development decisions with confidence. This is why 23 of the world’s top 25 drug developers trust us.

Find out more